Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics

Сергей Иванович Черныш, Андрей Юрьевич Яковлев, Наталья Александровна Гордя, Дмитрий Валентинович Тулин

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Purpose: The aim of this study is to improve the anti-biofilm activity of antibiotics. We hypothesized that the antimicrobial peptide (AMP) complex of the host’s immune system can be used for this purpose and examined the assumption on model biofilms. Methods: FLIP7, the AMP complex of the blowfly Calliphora vicina containing a combination of defensins, cecropins, diptericins and proline-rich peptides was isolated from the hemolymph of bacteria-challenged maggots. The complex interaction with antibiotics of various classes was studied in biofilm and planktonic cultures of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii by the checkerboard method using trimethyl tetrazolium chloride cell viability and crystal violet biofilm eradication assays supplemented with microscopic analysis. Results: We found that FLIP7 demonstrated: high synergy (fractional inhibitory concentration index <0.25) with meropenem, amikacin, kanamycin, ampicillin, vancomycin and cefotaxime; synergy with clindamycin, erythromycin and chloramphenicol; additive interaction with oxacillin, tetracycline, ciprofloxacin and gentamicin; and no interaction with polymyxin B. The interaction in planktonic cell models was significantly weaker than in biofilms of the same strains. The analysis of the dose-effect curves pointed to persister cells as a likely target of FLIP7 synergistic effect. The biofilm eradication assay showed that the effect also caused total destruction of S. aureus and E. coli biofilm materials. The effect allowed reducing the effective anti-biofilm concentration of the antibiotic to a level well below the one clinically achievable (2-3 orders of magnitude in the case of meropenem, ampicillin, cefotaxime and oxacillin). Conclusion: FLIP7 is a highly efficient host antimicrobial system helping antibiotics to overcome biofilm barriers through persisters’ sensitization and biofilm material destruction. It is promising for the treatment of biofilm infections as an adjuvant of various small-molecule antibiotics.

Original languageEnglish
Pages (from-to)501-514
Number of pages14
JournalInfection and Drug Resistance
Volume11
DOIs
StatePublished - 9 Apr 2018

Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Pharmacology

Keywords

  • Antibiotics
  • Biofilms
  • Calliphora vicina
  • Insect antimicrobial peptides
  • Persisters
  • Synergy
  • insect antimicrobial peptides
  • synergy
  • CLINICAL PHARMACOKINETICS
  • COMBINATION
  • GRAM-NEGATIVE BACTERIA
  • THERAPY
  • persisters
  • CRITICALLY-ILL PATIENTS
  • antibiotics
  • biofilms

Fingerprint

Dive into the research topics of 'Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics'. Together they form a unique fingerprint.

Cite this